Rheumatology - Rheumatology Academy

1-16 of 160

How Epithelial Cells Sustain Autoimmunity in Sjögren’s Disease
How Epithelial Cells Sustain Autoimmunity in Sjögren’s Disease
AudioAbstracts
How Epithelial Cells Sustain Autoimmunity in Sjögren’s Disease
Ryan Quigley
- Ryan Quigley
Sjögren’s-Related Dry Eye: Lifestyle and Supportive Measures
Sjögren’s-Related Dry Eye: Lifestyle and Supportive Measures
Living Rheum
Sjögren’s-Related Dry Eye: Lifestyle and Supportive Measures
Esen Akpek, MD
- Esen Akpek, MD
Diagnostic Testing and Treatment of Dry Eye in Sjögren’s Disease
Diagnostic Testing and Treatment of Dry Eye in Sjögren’s Disease
Living Rheum
Diagnostic Testing and Treatment of Dry Eye in Sjögren’s Disease
Esen Akpek, MD
- Esen Akpek, MD
A Look at Ocular Manifestations of Sjögren’s Disease
A Look at Ocular Manifestations of Sjögren’s Disease
Living Rheum
A Look at Ocular Manifestations of Sjögren’s Disease
Esen Akpek, MD
- Esen Akpek, MD
Delayed Diagnosis in Sjögren’s Disease Is Linked to Greater Burden
Delayed Diagnosis in Sjögren’s Disease Is Linked to Greater Burden
AudioAbstracts
Delayed Diagnosis in Sjögren’s Disease Is Linked to Greater Burden
Ryan Quigley
- Ryan Quigley
Unmet Needs in SLE: The Challenge of Achieving Sustained Disease Control
Unmet Needs in SLE: The Challenge of Achieving Sustained Disease Control
Living Rheum
Unmet Needs in SLE: The Challenge of Achieving Sustained Disease Control
Steve Jackson, PharmD; Maria Dall'Era, MD
- Steve Jackson, PharmD
- Maria Dall'Era, MD
Identifying and Diagnosing RA-Associated Interstitial Lung Disease
Identifying and Diagnosing RA-Associated Interstitial Lung Disease
Living Rheum
Identifying and Diagnosing RA-Associated Interstitial Lung Disease
Bryant England, MD, PhD
- Bryant England, MD, PhD
Choosing a JAK Inhibitor for Rheumatoid Arthritis
Choosing a JAK Inhibitor for Rheumatoid Arthritis
Living Rheum
Choosing a JAK Inhibitor for Rheumatoid Arthritis
Roy Fleischmann, MD, MACR
- Roy Fleischmann, MD, MACR
Shared Decision-Making in Rheumatoid Arthritis Care
Shared Decision-Making in Rheumatoid Arthritis Care
Living Rheum
Shared Decision-Making in Rheumatoid Arthritis Care
Elena Myasoedova, MD, PhD
- Elena Myasoedova, MD, PhD
Beyond the Black Box: JAK Inhibitor Safety in RA
Beyond the Black Box: JAK Inhibitor Safety in RA
Living Rheum
Beyond the Black Box: JAK Inhibitor Safety in RA
Roy Fleischmann, MD, MACR
- Roy Fleischmann, MD, MACR
What's Next for Sjögren's Disease Treatment?
What's Next for Sjögren's Disease Treatment?
Living Rheum
What's Next for Sjögren's Disease Treatment?
Nancy Carteron, MD
- Nancy Carteron, MD
IFNα Is Associated with a Distinct Immune Endotype in Sjögren’s Disease
IFNα Is Associated with a Distinct Immune Endotype in Sjögren’s Disease
Living Rheum
IFNα Is Associated with a Distinct Immune Endotype in Sjögren’s Disease
Understanding Fatigue in Sjögren's Disease
Understanding Fatigue in Sjögren's Disease
Living Rheum
Understanding Fatigue in Sjögren's Disease
Nancy Carteron, MD
- Nancy Carteron, MD
The Spectrum of Neurologic Conditions in Sjögren's Patients
The Spectrum of Neurologic Conditions in Sjögren's Patients
Living Rheum
The Spectrum of Neurologic Conditions in Sjögren's Patients
Nancy Carteron, MD
- Nancy Carteron, MD
Recognizing Loss of Treatment Response in Psoriatic Arthritis
Recognizing Loss of Treatment Response in Psoriatic Arthritis
Living Rheum
Recognizing Loss of Treatment Response in Psoriatic Arthritis
Philip Mease, MD, MACR
- Philip Mease, MD, MACR
The Potential Role of GLP-1s in Psoriatic Arthritis Management
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Living Rheum
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Philip Mease, MD, MACR
- Philip Mease, MD, MACR

Prev
1
2
3
…
9
10
Next

1/6